[1]
Aravind M and Manojkrishnan C G, “COVID 19: Effect on leading pharmaceutical stocks listed with NSE”, Int. J. Res. Pharm. Sci., vol. 11, no. (SPL 1), pp. 31–36, Apr. 2020.